Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Pembrolizumab and Paclitaxel for Early Triple-Negative Breast Cancer in Patients with High Tumor-Infiltrating Lymphocytes

    Recruiting

    2 1 1 1
    Investigated drugs:
    France Spain
  • Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

    Recruiting

    2 1 1 1
    Spain Sweden
  • Study on Edotreotide for Detecting Somatostatin Receptors in Patients with Metastatic Breast Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on 18F-FES PET/MRI for Patients with Luminal A and Lobular Breast Cancer to Improve Treatment Decisions

    Recruiting

    2 1 1 1
    Italy
  • Study on Tucatinib, Capecitabine, and Trastuzumab for Patients with HER2-Positive Breast Cancer and Leptomeningeal Metastases

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Long-term Safety Study of Niraparib for Patients with Advanced Ovarian, Breast, or Prostate Cancer Who Completed a Previous Niraparib Study

    Recruiting

    2 1 1 1
    Austria France Germany Italy Romania Spain
  • Study on Extended Endocrine Therapy for High-Risk Breast Cancer Patients Using Tamoxifen, Exemestane, Anastrozole, and Letrozole

    Recruiting

    3 1 1 1
    Investigated diseases:
    Sweden
  • Study on Anastrozole, Letrozole, Exemestane, and Tamoxifen for Women Aged 70+ with Early Stage Breast Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Italy
  • Study on Optimizing CDK 4/6 Inhibitors and Endocrine Therapy for Older Patients with Advanced Breast Cancer Using Abemaciclib, Palbociclib, and Ribociclib

    Recruiting

    3 1 1 1
    Investigated diseases:
    Finland Greece Italy Norway Spain Sweden
  • Study of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium Ireland Italy The Netherlands Portugal Spain